36715843|t|Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
36715843|a|Parkinson's disease (PD) is a neuro-motor ailment that strikes adults in their older life and results in both motor and non-motor impairments. In neuronal and glial cells, PD has recently been linked to a dysregulated autophagic system and cerebral inflammation. Chloroquine (CQ), an anti-malarial drug, has been demonstrated to suppress autophagy in a variety of diseases, including cerebral ischemia, Alzheimer's disease (AD), and Traumatic brain injury (TBI), while its involvement in PD is still unclear. BALB/c mice were randomly allocated to one of four groups: 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP), CQ treatment with or without MPTP, or control. The CQ treatment group received CQ (intraperitoneally, 8 mg/kg body weight) after 1 h of MPTP induction on day 1, and it lasted for 7 days. CQ therapy preserves dopamine levels stable, inhibits tyrosine hydroxylase (TH) positive dopaminergic cell death, and lowers oxidative stress. CQ reduces the behavioural, motor, and cognitive deficits caused by MPTP after injury. Furthermore, CQ therapy slowed aberrant neuronal autophagy (microtubule-associated protein-1 light chain 3B; LC3B & Beclin1) and lowered expression levels of the inflammatory cytokines interleukin 1 (IL-1beta) and tumour necrosis factor (TNF-alpha) in the mice brain. In addition, CQ's antioxidant and anti-inflammatory effects were also tested in MPTP-mediated cell death in PC12 cells, demonstrating that CQ has a neurorestorative impact by successfully rescuing MPTP-induced ROS generation and cell loss. Our findings show that CQ's can help to prevent dopaminergic degeneration and improve neurological function after MPTP intoxication by lowering the harmful effects of neuronal autophagy and cerebral inflammation.
36715843	24	35	chloroquine	Chemical	MESH:D002738
36715843	68	85	neuroinflammation	Disease	MESH:D000090862
36715843	89	93	MPTP	Chemical	MESH:D015632
36715843	102	121	Parkinson's disease	Disease	MESH:D010300
36715843	123	142	Parkinson's disease	Disease	MESH:D010300
36715843	144	146	PD	Disease	MESH:D010300
36715843	153	172	neuro-motor ailment	Disease	MESH:C536203
36715843	233	264	motor and non-motor impairments	Disease	MESH:D000068079
36715843	295	297	PD	Disease	MESH:D010300
36715843	363	384	cerebral inflammation	Disease	MESH:D007249
36715843	386	397	Chloroquine	Chemical	MESH:D002738
36715843	399	401	CQ	Chemical	MESH:D002738
36715843	507	524	cerebral ischemia	Disease	MESH:D002545
36715843	526	545	Alzheimer's disease	Disease	MESH:D000544
36715843	547	549	AD	Disease	MESH:D000544
36715843	556	578	Traumatic brain injury	Disease	MESH:D000070642
36715843	580	583	TBI	Disease	MESH:D000070642
36715843	611	613	PD	Disease	MESH:D010300
36715843	632	638	BALB/c	CellLine	CVCL:0184
36715843	639	643	mice	Species	10090
36715843	691	738	1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine	Chemical	MESH:D015632
36715843	740	744	MPTP	Chemical	MESH:D015632
36715843	747	749	CQ	Chemical	MESH:D002738
36715843	776	780	MPTP	Chemical	MESH:D015632
36715843	798	800	CQ	Chemical	MESH:D002738
36715843	826	828	CQ	Chemical	MESH:D002738
36715843	883	887	MPTP	Chemical	MESH:D015632
36715843	934	936	CQ	Chemical	MESH:D002738
36715843	955	963	dopamine	Chemical	MESH:D004298
36715843	988	1008	tyrosine hydroxylase	Gene	21823
36715843	1010	1012	TH	Gene	21823
36715843	1077	1079	CQ	Chemical	MESH:D002738
36715843	1092	1134	behavioural, motor, and cognitive deficits	Disease	MESH:D003072
36715843	1145	1149	MPTP	Chemical	MESH:D015632
36715843	1177	1179	CQ	Chemical	MESH:D002738
36715843	1273	1277	LC3B	Gene	67443
36715843	1280	1287	Beclin1	Gene	56208
36715843	1326	1338	inflammatory	Disease	MESH:D007249
36715843	1364	1372	IL-1beta	Gene	16176
36715843	1402	1411	TNF-alpha	Gene	21926
36715843	1420	1424	mice	Species	10090
36715843	1445	1449	CQ's	Chemical	MESH:D002738
36715843	1471	1483	inflammatory	Disease	MESH:D007249
36715843	1512	1516	MPTP	Chemical	MESH:D015632
36715843	1540	1544	PC12	CellLine	CVCL:0481
36715843	1571	1573	CQ	Chemical	MESH:D002738
36715843	1629	1633	MPTP	Chemical	MESH:D015632
36715843	1642	1645	ROS	Chemical	-
36715843	1695	1699	CQ's	Chemical	MESH:D002738
36715843	1720	1745	dopaminergic degeneration	Disease	MESH:D009410
36715843	1786	1790	MPTP	Chemical	MESH:D015632
36715843	1862	1883	cerebral inflammation	Disease	MESH:D007249
36715843	Negative_Correlation	MESH:D002738	56208
36715843	Negative_Correlation	MESH:D002738	21926
36715843	Association	MESH:D007249	21926
36715843	Negative_Correlation	MESH:D002738	MESH:D002545
36715843	Negative_Correlation	MESH:D002738	67443
36715843	Association	MESH:D002738	MESH:D000090862
36715843	Positive_Correlation	MESH:D015632	MESH:D003072
36715843	Negative_Correlation	MESH:D002738	21823
36715843	Negative_Correlation	MESH:D002738	MESH:D003072
36715843	Positive_Correlation	MESH:D015632	MESH:D010300
36715843	Association	MESH:D007249	16176
36715843	Negative_Correlation	MESH:D002738	MESH:D000544
36715843	Negative_Correlation	MESH:D002738	MESH:D015632
36715843	Negative_Correlation	MESH:D002738	MESH:D009410
36715843	Negative_Correlation	MESH:D002738	MESH:D004298
36715843	Negative_Correlation	MESH:D002738	MESH:D000070642
36715843	Negative_Correlation	MESH:D002738	MESH:D010300
36715843	Negative_Correlation	MESH:D002738	16176
36715843	Negative_Correlation	MESH:D002738	MESH:D007249

